Share

March 30, 2021; 96 (13) Editorial

A Good Start to Shed More Light on the Relationship Between Glycemic Traits, Diabetes Mellitus, and Cerebrovascular Disease

Markus Arnold, Dipender Gill, Mira Katan
First published January 25, 2021, DOI: https://doi.org/10.1212/WNL.0000000000011557
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
71

Share

Article Information

vol. 96 no. 13 602-603
DOI: 
https://doi.org/10.1212/WNL.0000000000011557
PubMed: 
33495379
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • First Published January 25, 2021.

Article Versions

Copyright & Usage: 
© 2021 American Academy of Neurology

Author Disclosures

    1. Markus Arnold, MD,
    2. Dipender Gill, BMBCh, PhD and
    3. Mira Katan, MD, MSc
  1. Markus Arnold, MD,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Dipender Gill, BMBCh, PhD and
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. I have been employed as a Specialist in the Genetics Department of Novo Nordisk Research Centre Oxford since 1 April 2020.

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Mira Katan, MD, MSc
    4. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. STROKE, editorial board, since 2017 Neurology, editorial board since 2018 European Stroke Journal, editorial board since 2019 Frontiers in Neurology, editorial board since 2019

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. I received within the last 9 years an unrestricted research grants from BRAHMS/ Thermo Fisher Scientific as well as in kind contributions (Assays) (last in kind contribution in 2020). I received in kind contributions (Assays) from Roche in 2018.

    Research Support, Government Entities:

    1. I received several within the last 10 years research grants from the Swiss National Science Foundation (currently one grant is ongoing). Moreover I did receive a career developing grant form the Spital-Pool of the University Hospital of Zurich (until 2019)

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. I received a transatlantic career award from the Fondation Leducq and support form the Swiss Heart Foundation and I am receiving a career developing grant form the Baasch Medicus Foundation.

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From the Department of Neurology (M.A., M.K.), University Hospital of Zurich, Switzerland; and Department of Epidemiology and Biostatistics (D.G.), School of Public Health, Imperial College London, UK.
  1. Correspondence
    Dr. Arnold: markus.arnold{at}usz.ch
View Full Text

Article usage

Article usage: January 2021 to April 2023

AbstractFullPdfSource
Jan 2021008Highwire
Feb 2021008Highwire
Mar 20212042915Highwire
Apr 202116879Highwire
May 20217322Highwire
Jun 202111835Highwire
Jul 20214022Highwire
Aug 20214011Highwire
Sep 20214901Highwire
Oct 202112483Highwire
Nov 202112212Highwire
Dec 20214301Highwire
Jan 20224511Highwire
Feb 202210933Highwire
Mar 20224132Highwire
Apr 20224000Highwire
May 20222122Highwire
Jun 20221600Highwire
Jul 20222801Highwire
Aug 20223122Highwire
Sep 20222900Highwire
Oct 20222900Highwire
Nov 20224231Highwire
Dec 20224900Highwire
Jan 20235011Highwire
Feb 20232300Highwire
Mar 20233500Highwire
Apr 20232001Highwire

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

Topics Discussed

Alert Me

Recommended articles